N-Propargylglycine is a brain-penetrant and orally active PRODH inhibitor. It functions by inhibiting proline and 4-hydroxyproline catabolism, enhancing mitochondrial proteostasis, and stimulating neural processes. This compound is used in research for various neurodegenerative disorders, breast cancer, and primary hyperoxaluria type 2.
- Brain-penetrant and orally active PRODH inhibitor
- Inhibits proline and 4-hydroxyproline catabolism
- Enhances mitochondrial proteostasis
- Stimulates neural processes
- Useful in research for neurodegenerative disorders and breast cancer
- Reduces hyperoxaluria and prevents calcium oxalate stone formation